Skip to main content
LIGAND PHARMACEUTICALS INC logo

LIGAND PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · LGND ISIN · US53220K5048 LEI · 5493008K7TB0IKP37H79 US Financial and insurance activities
Open in API
Filings indexed 1,392 across all filing types
Latest filing 2014-08-21 Major Shareholding Noti…
Country US United States of America
Listing US LGND

About LIGAND PHARMACEUTICALS INC

https://www.ligand.com/

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that functions as a capital and technology partner to the life sciences industry. The company's business model focuses on acquiring and developing royalty-generating assets by investing in the clinical development and commercialization of medicines. It manages a large, diverse portfolio of economic rights to partnered programs across therapeutic areas such as oncology, kidney disease, diabetes, and rare conditions. In addition to its royalty business, Ligand develops and licenses its proprietary technology platforms to a global network of biopharmaceutical partners. Its key technologies include Captisol®, a chemically modified cyclodextrin used to improve the solubility and stability of active pharmaceutical ingredients, and the NITRICIL™ platform.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2014
Major Shareholding Notification
2014-08-21 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the issuance of convertible senior notes, related hedge and warrant transactions, and the use of proceeds. It includes detailed information about a financing transaction, including terms of the notes, hedge transactions, warrant transactions, and use of proceeds. This fits the category of a Capital/Financing Update, as it reports on new debt issuance and related financial arrangements. The document is not an annual or quarterly report, audit report, earnings release, or other categories. It is a detailed disclosure of a financing event, consistent with the Capital/Financing Update (CAP) category. The document length is substantial and contains detailed financial terms, not just an announcement or certification, so it is not RPA or RNS. Therefore, the correct classification is CAP with high confidence.
2014-08-18 English
PRIMARY DOCUMENT
Director's Dealing
2014-08-15 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated August 12, 2014. It announces the pricing of $225 million aggregate principal amount of 0.75% convertible senior notes due 2019 in a private offering. The content is primarily an announcement of a financing event, specifically a capital raising through convertible notes. There are no financial statements or detailed financial analysis included, just a press release incorporated by reference. The document length is 2546 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing fits best under the category of Capital/Financing Update (CAP).
2014-08-13 English
FORM 8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The text specifically mentions the company announcing its intention to offer $225 million of convertible senior notes in a private offering. This is a clear update on the company's financing activities. The document includes a press release about this offering and does not contain financial statements or detailed financial analysis. Therefore, it is an update on capital raising or financing activities, fitting the Capital/Financing Update (CAP) category. The document length is short and focused on this financing event, not a full financial report or earnings release.
2014-08-11 English
10-Q
Interim / Quarterly Report Q2 2014
2014-08-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.